Paper41310342
Eltrombopag olamine induces apoptosis in human breast adenocarcinoma and hepatocellular carcinoma cells through modulation of multiple apoptotic pathways.
Kabir SR and 3 others. Sci Rep, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Eltrombopag olamine induces apoptosis in human breast adenocarcinoma and hepatocellular carcinoma cells through modulation of multiple apoptotic pathways. Papers, record 41310342. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41310342
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Eltrombopag olamine induces apoptosis in human breast adenocarcinoma and hepatocellular carcinoma cells through modulation of multiple apoptotic pathways.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Apoptosis | Major topic |
| Hydrazines | Major topic |
| Breast Neoplasms | Major topic |
| Pyrazoles | Major topic |
| Carcinoma, Hepatocellular | Major topic |
| Liver Neoplasms | Major topic |
| Benzoates | Major topic |
| Antineoplastic Agents | Major topic |
| Adenocarcinoma | Major topic |
| Humans | |
| Female | |
| MCF-7 Cells | |
| Cell Line, Tumor | |
| Signal Transduction | |
| Cell Proliferation | |
| HEK293 Cells |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11821415 | ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53. | J Biol Chem | 2002 | https://conductscience.org/library/papers/11821415 | PubMed |
| 2 | 19782763 | Caspase-7: a protease involved in apoptosis and inflammation. | Int J Biochem Cell Biol | 2010 | https://conductscience.org/library/papers/19782763 | PubMed |
| 3 | 36834574 | Eltrombopag Inhibits Metastasis in Breast Carcinoma by Targeting HuR Protein. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36834574 | PubMed |
| 4 | 27861627 | Caspase-Dependent and Caspase-Independent Pathways Are Involved in Cadmium-Induced Apoptosis in Primary Rat Proximal Tubular Cell Culture. | PLoS One | 2016 | https://conductscience.org/library/papers/27861627 | PubMed |
| 5 | 36695998 | Novel pentacyclic derivatives and benzylidenes of the progesterone series cause anti-estrogenic and antiproliferative effects and induce apoptosis in breast cancer cells. | Invest New Drugs | 2023 | https://conductscience.org/library/papers/36695998 | PubMed |
| 6 | 40630953 | The role of notch signaling pathway in cancer: mechanistic insights, therapeutic potential, and clinical progress. | Front Immunol | 2025 | https://conductscience.org/library/papers/40630953 | PubMed |
| 7 | 30310233 | Drug repurposing: progress, challenges and recommendations. | Nat Rev Drug Discov | 2019 | https://conductscience.org/library/papers/30310233 | PubMed |
| 8 | 36964397 | 2,4-Dipropylphloroglucinol inhibits the growth of human lung and colorectal cancer cells through induction of apoptosis. | Med Oncol | 2023 | https://conductscience.org/library/papers/36964397 | PubMed |
| 9 | 10438458 | Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells. | J Biol Chem | 1999 | https://conductscience.org/library/papers/10438458 | PubMed |
| 10 | 35335147 | Significant Roles of Notch O-Glycosylation in Cancer. | Molecules | 2022 | https://conductscience.org/library/papers/35335147 | PubMed |
| 11 | 40206274 | Unraveling the Role of the Wnt Pathway in Hepatocellular Carcinoma: From Molecular Mechanisms to Therapeutic Implications. | J Clin Transl Hepatol | 2025 | https://conductscience.org/library/papers/40206274 | PubMed |
| 12 | 36878052 | Investigating regulated signaling pathways in therapeutic targeting of non-small cell lung carcinoma. | Biomed Pharmacother | 2023 | https://conductscience.org/library/papers/36878052 | PubMed |
| 13 | 26397763 | The Eltrombopag antitumor effect on hepatocellular carcinoma. | Int J Oncol | 2015 | https://conductscience.org/library/papers/26397763 | PubMed |
| 14 | 39856369 | Mechanistic insights into Wnt-β-catenin pathway activation and signal transduction. | Nat Rev Mol Cell Biol | 2025 | https://conductscience.org/library/papers/39856369 | PubMed |
| 15 | 31731457 | STAT3: An Emerging Therapeutic Target for Hepatocellular Carcinoma. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/31731457 | PubMed |
| 16 | 36527492 | Antimycin A induced apoptosis in HCT-116 colorectal cancer cells through the up- and downregulation of multiple signaling pathways. | Med Oncol | 2022 | https://conductscience.org/library/papers/36527492 | PubMed |
| 17 | 18046027 | Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C. | N Engl J Med | 2007 | https://conductscience.org/library/papers/18046027 | PubMed |
| 18 | 40170063 | Wnt signaling in cancer: from biomarkers to targeted therapies and clinical translation. | Mol Cancer | 2025 | https://conductscience.org/library/papers/40170063 | PubMed |
| 19 | 15286780 | Cancer genes and the pathways they control. | Nat Med | 2004 | https://conductscience.org/library/papers/15286780 | PubMed |
| 20 | 39290346 | Asparagus racemosus silver chloride nanoparticles and Kaempferia rotunda mediated silver/silver chloride nanoparticles inhibit human hepatocellular and lung cancer cell lines. | Biochem Biophys Rep | 2024 | https://conductscience.org/library/papers/39290346 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41977432 | Preclinical Evaluation of Triptophenolide-Induced Apoptosis in Hepatoblastoma (HepG2) and Hepatocellular Carcinoma (HuH7) Cell Lines. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41977432 |
Source PubMed
Genes11
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ANXA5 | 308 | PubTator's text mining | https://conductscience.org/library/genes/308 | NCBI Gene |
| BAX | 581 | PubTator's text mining | https://conductscience.org/library/genes/581 | NCBI Gene |
| CYCS | 54205 | PubTator's text mining | https://conductscience.org/library/genes/54205 | NCBI Gene |
| EGFR | 1956 | PubTator's text mining | https://conductscience.org/library/genes/1956 | NCBI Gene |
| FAS | 355 | PubTator's text mining | https://conductscience.org/library/genes/355 | NCBI Gene |
| MAPK1 | 5594 | PubTator's text mining | https://conductscience.org/library/genes/5594 | NCBI Gene |
| PARP1 | 142 | PubTator's text mining | https://conductscience.org/library/genes/142 | NCBI Gene |
| STAT3 | 6774 | PubTator's text mining | https://conductscience.org/library/genes/6774 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
| WNT1 | 7471 | PubTator's text mining | https://conductscience.org/library/genes/7471 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41310342
GET https://conductscience.org/api/papers/v1/41310342/references?page=2